Importantly, the novel fast-acting antidepressant drug ketamine exerts therapeutic effects via rapid modulation of protein synthesis, including translational initiation3 and elongation2, and mTOR signaling57, providing an additional link between translational regulation of the proteome and the neurobiology and treatment of depression and anxiety. This evidence concerns the gene MTOR and depressive symptom measurement.